MEDIDATA SOLUTIONS INC (MDSO) Stock Price & Overview
NASDAQ:MDSO
Current stock price
The current stock price of MDSO is 92.22 null. Today MDSO is down by -0.02%. In the past month the price increased by 0.79%. In the past year, price increased by 28.57%.
MDSO Key Statistics
- Market Cap
- 5.76B
- P/E
- 106.00
- Fwd P/E
- 91.31
- EPS (TTM)
- 0.87
- Dividend Yield
- N/A
MDSO Stock Performance
MDSO Stock Chart
MDSO Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to MDSO. When comparing the yearly performance of all stocks, MDSO is one of the better performing stocks in the market, outperforming 83.65% of all stocks.
MDSO Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MDSO. MDSO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
MDSO Earnings
MDSO Forecast & Estimates
MDSO Financial Highlights
Over the last trailing twelve months MDSO reported a non-GAAP Earnings per Share(EPS) of 0.87. The EPS decreased by -10.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.43% | ||
| ROA | 4.3% | ||
| ROE | 6.67% | ||
| Debt/Equity | 0.27 |
MDSO Ownership
About MDSO
Company Profile
Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies.
Company Info
MEDIDATA SOLUTIONS INC
350 HUDSON ST. 9TH FLOOR
NEW YORK NY 10014
CEO: Tarek A. Sherif
Phone: 212-918-1800
MEDIDATA SOLUTIONS INC / MDSO FAQ
What does MDSO do?
Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies.
What is the stock price of MEDIDATA SOLUTIONS INC today?
The current stock price of MDSO is 92.22 null. The price decreased by -0.02% in the last trading session.
Does MEDIDATA SOLUTIONS INC pay dividends?
MDSO does not pay a dividend.
What is the ChartMill technical and fundamental rating of MDSO stock?
MDSO has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Should I buy MDSO stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MDSO.